Article
BTIG Maintains Buy on Hims & Hers Health, Lowers Price Target to $60
BTIG analyst David Larsen maintains Hims & Hers Health (NYSE:HIMS) with a Buy and lowers the price target from $85 to $60.
Comments
- No comments yet. Be the first to comment!